These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22106974)

  • 1. Type 2 diabetes and cardiovascular risk factors.
    Sharma MD; Farmer JA; Garber A
    Curr Med Res Opin; 2011 Nov; 27 Suppl 3():1-5. PubMed ID: 22106974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of glycemic treatment choices on cardiovascular complications in type 2 diabetes.
    Weiss IA; Valiquette G; Schwarcz MD
    Cardiol Rev; 2009; 17(4):165-75. PubMed ID: 19525678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
    Dailey G
    Clin Ther; 2011 Jun; 33(6):665-78. PubMed ID: 21704233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [How effectively should hyperglycemia be treated in a type 2 diabetes patient?].
    Eriksson J
    Duodecim; 2009; 125(13):1387-94. PubMed ID: 19678494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycemic targets for patients with type 2 diabetes mellitus.
    Hamnvik OP; McMahon GT
    Mt Sinai J Med; 2009 Jun; 76(3):227-33. PubMed ID: 19421966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postprandial glucose regulation and diabetic complications.
    Ceriello A; Hanefeld M; Leiter L; Monnier L; Moses A; Owens D; Tajima N; Tuomilehto J
    Arch Intern Med; 2004 Oct; 164(19):2090-5. PubMed ID: 15505121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes mellitus and cardiovascular disease. Pandora's box has been opened.
    Berry J; Keebler ME; McGuire DK
    Herz; 2004 Aug; 29(5):456-62. PubMed ID: 15340730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension and diabetes mellitus are associated with cardiovascular events in the elderly without cardiovascular disease. Results of a 15-year follow-up in a Mediterranean population.
    Noto D; Cefalù AB; Barbagallo CM; Sapienza M; Cavera G; Nardi I; Pagano M; Vivona N; Notarbartolo A; Averna MR
    Nutr Metab Cardiovasc Dis; 2009 Jun; 19(5):321-6. PubMed ID: 18571394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Postprandial hyperglycemia. Cardiovascular risks and new therapeutic strategies].
    Sjöholm A
    Lakartidningen; 2001 Feb; 98(9):937-40. PubMed ID: 11292972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular disease in type 2 diabetics: epidemiology, risk factors and therapeutic modalities.
    Khamaisi M; Wexler ID; Skrha J; Strojek K; Raz I; Milicevic Z
    Isr Med Assoc J; 2003 Nov; 5(11):801-6. PubMed ID: 14650106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute glucose fluctuations and chronic sustained hyperglycemia as risk factors for cardiovascular diseases in patients with type 2 diabetes.
    Colette C; Monnier L
    Horm Metab Res; 2007 Sep; 39(9):683-6. PubMed ID: 17846977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating the diabetic patient: appropriate care for glycemic control and cardiovascular disease risk factors.
    Zarich SW
    Rev Cardiovasc Med; 2003; 4 Suppl 6():S19-28. PubMed ID: 14668700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular manifestations of insulin resistance.
    Chahwala V; Arora R
    Am J Ther; 2009; 16(5):e14-28. PubMed ID: 19114874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal diabetes management during medical weight loss for cardiovascular risk reduction.
    Nori Janosz KE; Miller WM; Odom J; Lillystone M; McCullough PA
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):761-75. PubMed ID: 16076284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiology of cardio-vascular complications of diabetes].
    Grimaldi A; Heurtier A
    Diabetes Metab; 1999 Jun; 25 Suppl 3():12-20. PubMed ID: 10421988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding type 2 diabetes mellitus and associated cardiovascular disease: linked by insulin resistance.
    Tennyson GE
    Am J Manag Care; 2002 Oct; 8(16 Suppl):S450-9. PubMed ID: 12408408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing cardiovascular disease risk in patients with type 2 diabetes and concomitant macrovascular disease: can insulin be too much of a good thing?
    Rensing KL; Reuwer AQ; Arsenault BJ; von der Thüsen JH; Hoekstra JB; Kastelein JJ; Twickler TB
    Diabetes Obes Metab; 2011 Dec; 13(12):1073-87. PubMed ID: 21736687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of insulin therapy on macrovascular risk factors in type 2 diabetes.
    Boyne MS; Saudek CD
    Diabetes Care; 1999 Apr; 22 Suppl 3():C45-53. PubMed ID: 10189562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and risk factors of macrovascular disease in diabetes mellitus.
    Janka HU
    Horm Metab Res Suppl; 1990; 22():8-11. PubMed ID: 2202634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multifactorial approach of the cardiovascular risks in case of diabetes].
    Ducobu J
    Rev Med Brux; 2005 Sep; 26(4):S255-63. PubMed ID: 16240871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.